DPH — Dechra Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- £4.40bn
- £4.83bn
- £761.50m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 39 | 52.2 | 84 | 95.5 | 6.3 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 79 | 69.8 | 77.7 | 6.5 | 73.5 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -46 | -29.8 | -88.1 | -68.2 | -106 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 81.8 | 106 | 89.1 | 123 | 63.6 |
Capital Expenditures | -22.5 | -49.2 | -135 | -77.6 | -30.3 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -39.4 | -32.3 | -1.3 | -0.7 | -396 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -61.9 | -81.5 | -136 | -78.3 | -426 |
Financing Cash Flow Items | -0.2 | -1.7 | 0 | — | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -20.1 | 119 | -55.1 | -46.1 | 317 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.6 | 147 | -109 | 2.5 | -46.5 |